KR20120018609A - Aqueous nanoemulsion composition containing mastic gum - Google Patents

Aqueous nanoemulsion composition containing mastic gum Download PDF

Info

Publication number
KR20120018609A
KR20120018609A KR1020100081556A KR20100081556A KR20120018609A KR 20120018609 A KR20120018609 A KR 20120018609A KR 1020100081556 A KR1020100081556 A KR 1020100081556A KR 20100081556 A KR20100081556 A KR 20100081556A KR 20120018609 A KR20120018609 A KR 20120018609A
Authority
KR
South Korea
Prior art keywords
mastic gum
oil
acid ester
nanoemulsion composition
weight
Prior art date
Application number
KR1020100081556A
Other languages
Korean (ko)
Inventor
지홍근
유효경
현인숙
Original Assignee
주식회사 엠앤씨워터
유효경
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엠앤씨워터, 유효경 filed Critical 주식회사 엠앤씨워터
Priority to KR1020100081556A priority Critical patent/KR20120018609A/en
Publication of KR20120018609A publication Critical patent/KR20120018609A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nanotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

PURPOSE: An aqueous nanoemulsion composition containing mastic gum is provided to ensure bioavailability and for excellent storage and pH stability. CONSTITUTION: An aqueous nanoemulsion composition containing mastic gum contains 5-60 wt% of mastic gum, 5-50 wt% of oil, 3-30 wt% of polyglycerin fatty acid ester as an emulsifier, 0.1-15 wt% of sugar fatty acid ester, 1-40 wt% of propylene glycol, and water for the remaining amount. The mastic gum is obtained from Pistacia lentiscus. The viscosity of the composition is 1-100 Cp. The oil includes olive oil, sunflower seed oil, MCT(medium chain triglyceride), jojoba oil, or macadamia oil. The polyglycerin fatty acid ester includes polyglycerin stearic acid, polyglycerin myristic acid, polyglycerin oleic acid, or polyglycerin lauric acid.

Description

매스틱검을 함유하는 수성 나노에멀젼 조성물{AQUEOUS NANOEMULSION COMPOSITION CONTAINING MASTIC GUM}Aqueous nanoemulsion composition containing mastic gum {AQUEOUS NANOEMULSION COMPOSITION CONTAINING MASTIC GUM}

본 발명은 매스틱검 5 내지 60 중량%, 오일 5 내지 50 중량%, 유화제로 폴리글리세린 지방산 에스테르 3 내지 30 중량%, 보조 유화제로 자당 지방산 에스테르 0.1 내지 15 중량%, 프로필렌글리콜 1 내지 40 중량% 및 잔량의 물을 포함하는 매스틱검 함유 수성 나노에멀젼 조성물에 관한 것으로 본 발명의 매스틱검 함유 수성 나노에멀젼 조성물은 생체 이용률이 높고, 뛰어난 저장 안정성 및 pH 안정성을 갖는다.The present invention is 5 to 60% by weight mastic gum, 5 to 50% by weight oil, 3 to 30% by weight polyglycerin fatty acid ester as emulsifier, 0.1 to 15% by weight sucrose fatty acid ester as auxiliary emulsifier, 1 to 40% by weight propylene glycol And it relates to a mastic gum-containing aqueous nanoemulsion composition comprising a residual amount of water, the mastic gum-containing aqueous nanoemulsion composition of the present invention has a high bioavailability, has excellent storage stability and pH stability.

매스틱(mastic) 나무(Pistacia lentiscus)는 옻나무과의 상록 관목으로 키가 2 내지 3미터이고, 생장 속도가 아주 느려서 40 내지 50년이 지나야 다 자라며, 5년생 나무부터 검(gum)을 생산해 낸다. 매스틱 나무는 100년이 넘도록 살지만 70년 정도 되면 늙기 시작한다. 오직 그리스 키오스(Chios) 섬의 남부에서만 독점적으로 재배되는 Chia 변종만이 순수하고 독특한 최상급의 매스틱검을 생산해 낸다. 바로 키오스 섬에서만 나타나는 이 식물의 변종, 미기후(微氣候, microclimate), 풍토 등이 매스틱 생산에 결정적인 것이다. 매스틱은 화학물질이 전혀 첨가되지 않은 천연물질로서 그리스의 키오스 섬에서만 자라는 매스틱 나무의 수액이다. 매스틱의 수확은 7월부터 10월 초까지 이루어지는데 수액을 얻기 위해 날카로운 연장으로 매스틱 나무에 상처를 내어 분비물이 나오게 한다. 매스틱은 상처 위에서 눈물방울 모양처럼 흐르며 방울지어 땅 위로 떨어진다. 매스틱은 크리스탈처럼 투명하여 처음에는 좀 쓴맛이 나지만, 이 쓴맛은 곧 사라지면서 독특한 아로마 향을 남긴다.
Mastic tree ( Pistacia lentiscus ) is an evergreen shrub of the family Sumacaceae. It is 2 to 3 meters tall, grows very slowly, and grows after 40 to 50 years, and produces gum from the 5 year old tree. Mastic trees live for over 100 years, but begin to age in about 70 years. Only Chia varieties, cultivated exclusively in the southern part of the Greek island of Chios, produce pure, unique and superlative mastic gum. Variants, microclimates, and climates of this plant, which are found only on the island of Chios, are crucial for mastic production. Mastic is a sap of a mastic tree that grows only on the Greek island of Chios, with no added chemicals. The harvest of the mastic takes place from July to early October, with a sharp extension that cuts the mastic tree and releases secretions to obtain sap. Mastic is like a teardrop on a wound Flows and drops fall to the ground. The mastic is crystal clear and has a bitter bite at first, but the bitter taste soon disappears, leaving a distinctive aroma.

매스틱은 고대 그리스 시대부터 치료제와 식품, 미용 등에 널리 쓰였으며, 최근에도 매스틱의 효능에 대해 다양한 연구가 진행되고 있다. 천연 키오스 매스틱이 치아를 둘러싸고 있는 균들의 해로운 영향(독성)을 어떻게 예방하는지 조사한 결과 체계적으로 키오스 매스틱을 씹었을 때, 아무것도 씹지 않았을 때와 비교하여 세균 플라크가 유의성 있는 수치인 41.5%가 감소하였다는 보고가 있었다(Keiso Takahashi, 2003). 노팅험 대학교에서 실시된 연구들은 적은 양(하루에 1mg씩 2주간)의 매스틱이라도 헬리코박터 파일로리(Helicobacter pylori)로 인한 소화기 궤양을 치료할 수 있음을 밝혀냈다. 전자현미경 관찰 결과 매스틱이 헬리코박터 파일로리에 구조 변화를 일으키고, 이 활동이 매스틱의 항궤양 활동을 설명해 줄 수 있으며, 매스틱이 유문의 나선형 세균에 대해 항균 활동을 하는 성분을 함유하고 있음을 보여준다(New England Journal of Medicine, 1998). 그리스 아테네 대학교 약리학회는「매스틱 오일에서 추출한 매스틱 에센셜 오일의 화학 합성물과 항균 활동」에 관한 연구에서 “매스틱 오일이 주목할만한 항균 활성을 보였다. 또한, 아주 중요한 항진균 활성도 나타냈다”라고 보고했다(The Journal of Dermatologic Surgery and Oncology, 1992).
Mastic has been widely used in medicine, food and beauty since ancient Greek times, and various researches on the efficacy of mastic have been conducted. Investigating how the natural chios mastic prevents the harmful effects (toxicity) of the bacteria surrounding the teeth, 41.5% showed that bacterial plaques were significantly higher when chewing systematically than when nothing was chewed. Has been reported to decrease (Keiso Takahashi, 2003). Studies conducted at the University of Nottingham have shown that even a small amount of mastic (1 mg per day for 2 weeks) is a Helicobacter. pylori ) has been shown to be able to cure peptic ulcer disease. Electron microscopic observations show that mastic causes structural changes in Helicobacter pylori, which may explain the anti-ulcer activity of mastic, and that mastic contains antibacterial activity against pyloric spiral bacteria. (New England Journal of Medicine, 1998). In a study on the chemical composition and antibacterial activity of mastic essential oils extracted from mastic oil, the Greek pharmacological society said, “Mastic oil has shown notable antimicrobial activity. It also showed significant antifungal activity ”(The Journal of Dermatologic Surgery and Oncology, 1992).

식품, 음료, 화장품이나 제약 등의 분야에서 사용하는 기능성 물질들은 천연물질들이 많은데 대부분의 기능성 물질들이 뛰어난 효능/효과를 나타냄에도 불구하고, 외부적인 환경요인, 즉 빛, 열, 산소 등에 매우 불안정하고, 물이나 일반적인 유기용매, 오일 등에 녹지 않아 그 사용이 제한적일 수밖에 없고 이러한 물질들의 예는 일일이 다 열거할 수 없을 정도이다. 현재는 계면활성제나 유화제를 이용하여 용액 상에서 에멀젼(emulsion)이나 캡슐화(capsulation)하는 방법으로 안정화시켜 사용하고 있다. 그러나 이러한 방법들을 이용하면 마이셀(micelle)이 응집되거나 용액에서 기능성 물질의 확산에 의해 자체 분해되는 현상이 나타나서 물리적으로나 화학적으로 기능성 물질들을 충분하게 안정화시키지 못하고 있어 실제 산업에 사용하는데 한계가 있다. 그래서 각 분야에서는 이를 극복하고자 하는 연구들이 지속적으로 이루어지고는 있으나 뚜렷한 해결책이 제시되고 있지는 못한 상태이다.Functional materials used in the fields of food, beverages, cosmetics and pharmaceuticals have many natural materials. Although most functional materials show excellent efficacy / effect, they are very unstable to external environmental factors such as light, heat and oxygen. It is insoluble in water, general organic solvents and oils, so its use is limited and examples of such substances cannot be enumerated. Currently, it is used by stabilizing by emulsion or encapsulation in solution using surfactants or emulsifiers. However, when these methods are used, micelles are agglomerated or self-decompose by the diffusion of functional substances from solution. Therefore, the functional substances are not sufficiently stabilized physically and chemically, and thus there is a limitation in using them in actual industry. Thus, studies to overcome this problem have been continuously conducted in each field, but no clear solution has been proposed.

매스틱검의 경우도 그 효능이 과학적으로 연구되며, 껌, 치약, 스파, 화장품 등 다양한 형태로 그 활용도가 높아지고 있으나 매스틱검은 물에 용해가 쉽지 않아 이용에 제한이 많다.In the case of mastic gum, its efficacy is scientifically researched, and its utilization is increasing in various forms such as gum, toothpaste, spa, and cosmetics, but mastic gum is not easily dissolved in water, and thus there are many limitations in using it.

Keiso Takahashi et al., Journal of Periodontology, April 2003, Vol. 74, No.4, pp. 501-505Keiso Takahashi et al., Journal of Periodontology, April 2003, Vol. 74, No. 4, pp. 501-505 New England Journal of Medicine, Vol. 339, Issue 26, Dec. 24, 1998, p. 1946New England Journal of Medicine, Vol. 339, Issue 26, Dec. 24, 1998, p. 1946 The Journal of Dermatologic Surgery and Oncology, Volume 18, Issue 11, November 1992, p. 990The Journal of Dermatologic Surgery and Oncology, Volume 18, Issue 11, November 1992, p. 990

따라서 본 발명은 매스틱검을 유효성분으로 함유하면서 뛰어난 생체이용률, 저장 안정성, pH 안정성 등을 갖는 매스틱검 함유 수성 나노에멀젼 조성물을 제공하는 것을 그 기술적 과제로 한다.Accordingly, the present invention provides a mastic gum-containing aqueous nanoemulsion composition having excellent bioavailability, storage stability, pH stability and the like while containing mastic gum as an active ingredient.

상기 목적을 달성하기 위하여 본 발명은 매스틱검 5 내지 60 중량%, 오일 5 내지 50 중량%, 유화제로 폴리글리세린 지방산 에스테르 3 내지 30 중량%, 보조 유화제로 자당 지방산 에스테르 0.1 내지 15 중량%, 프로필렌글리콜 1 내지 40 중량% 및 잔량의 물을 포함하는 매스틱검 함유 수성 나노에멀젼 조성물을 제공한다.
In order to achieve the above object, the present invention provides 5 to 60% by weight of mastic gum, 5 to 50% by weight of oil, 3 to 30% by weight of polyglycerin fatty acid ester as emulsifier, 0.1 to 15% by weight of sucrose fatty acid ester as auxiliary emulsifier, propylene It provides a mastic gum-containing aqueous nanoemulsion composition comprising 1 to 40% by weight of glycol and the balance of water.

본 발명의 수성 나노에멀젼 조성물은 유효성분으로 매스틱검을 포함한다. 매스틱검은 용매에 용해가 쉽게 되지 않아 장시간이 소요될 수 있기에 본 발명의 수성 나노에멀젼 조성물의 제조에 있어 매스틱검을 용매에 직접 용해하는 것보다는 이를 분쇄기로 파쇄한 다음 용매에 용해하는 것이 더 바람직하다. 본 발명의 수성 나노에멀젼 조성물은 매스틱검을 5 내지 60 중량%, 더 바람직하게는 10 내지 50 중량%로 포함한다. 본 발명에서 매스틱검이 5 중량% 미만으로 포함되면 매스틱검의 생리활성 효과가 미약해질 수 있고, 60 중량%를 초과하여 포함되면 매스틱검이 잘 용해되지 않거나 장시간 노출시 석출이 될 수 있다.
The aqueous nanoemulsion composition of the present invention contains mastic gum as an active ingredient. Since mastic gum may not be easily dissolved in a solvent and may take a long time, it is more preferable to dissolve the mastic gum in a solvent and then to dissolve it in a solvent than to directly dissolve the mastic gum in a solvent. . The aqueous nanoemulsion composition of the present invention comprises mastic gum at 5 to 60% by weight, more preferably 10 to 50% by weight. When the mastic gum is included in less than 5% by weight in the present invention may be a weak biophysical effect of the mastic gum, when contained in excess of 60% by weight may be a good melted mastic gum or precipitated for a long time exposure. have.

본 발명의 수성 나노에멀젼 조성물은 매스틱검을 용해하기 위한 용매로 오일을 포함한다. 본 발명에서 오일은 매스틱검을 용해시킬 수 있는 한 특별한 제한은 없으나, 바람직하게는 올리브유, 해바라기유, MCT(medium chain triglyceride)유, 호호바유(jojoba oil) 또는 마카다미아넛오일이 단독 또는 혼합되어 사용될 수 있다. 본 발명의 수성 나노에멀젼 조성물은 오일을 5 내지 50 중량%, 더 바람직하게는 10 내지 40 중량%, 더 바람직하게는 15 내지 35 중량%로 포함한다. 본 발명에서 오일이 5 중량% 미만으로 포함되면 매스틱검의 용해가 어려워질 수 있고, 50 중량%를 초과하여 포함되면 유화 안정성이 저하될 수 있다.
The aqueous nanoemulsion composition of the present invention contains oil as a solvent for dissolving mastic gum. The oil in the present invention is not particularly limited as long as it can dissolve the mastic gum, but preferably olive oil, sunflower oil, medium chain triglyceride (MCT) oil, jojoba oil or macadamia nut oil may be used alone or in combination. Can be. The aqueous nanoemulsion composition of the present invention comprises 5 to 50% by weight of oil, more preferably 10 to 40% by weight, more preferably 15 to 35% by weight of oil. In the present invention, when the oil is included in less than 5% by weight it may be difficult to dissolve the mastic gum, and when included in more than 50% by weight may lower the emulsion stability.

본 발명의 수성 나노에멀젼 조성물은 유화제로 폴리글리세린 지방산 에스테르를 포함한다. 본 발명에서 폴리글리세린 지방산 에스테르는, 예를 들면 폴리글리세린 스테아린산, 폴리글리세린 미리스틴산, 폴리글리세린 올레인산 또는 폴리글리세린 라우린산이 단독 또는 혼합되어 사용될 수 있으나 이에 제한되는 것은 아니다. 본 발명의 수성 나노에멀젼 조성물은 폴리글리세린 지방산 에스테르를 3 내지 30 중량%, 더 바람직하게는 5 내지 20 중량%로 포함한다. 본 발명에서 폴리글리세린 지방산 에스테르가 3 중량% 미만으로 포함되면 유화 효과가 미약해지고 유화 안정성이 저하될 수 있으며, 30 중량%를 초과하여 포함되면 수성 조성물의 점성이 높아진다는 문제가 있을 수 있다.
The aqueous nanoemulsion composition of the present invention comprises a polyglycerol fatty acid ester as an emulsifier. In the present invention, the polyglycerol fatty acid ester, for example, polyglycerol stearic acid, polyglycerin myristic acid, polyglycerol oleic acid or polyglycerol lauric acid may be used alone or mixed but is not limited thereto. The aqueous nanoemulsion composition of the present invention comprises 3 to 30% by weight, more preferably 5 to 20% by weight of polyglycerin fatty acid ester. In the present invention, when the polyglycerol fatty acid ester is included in less than 3% by weight, the emulsification effect may be weak and the emulsion stability may be lowered. When the polyglycerol fatty acid is contained in an amount of more than 30% by weight, the viscosity of the aqueous composition may increase.

본 발명의 수성 나노에멀젼 조성물은 매스틱검을 보다 안정하게 유화시키기 위하여 보조 유화제로 자당 지방산 에스테르를 포함한다. 본 발명에서 자당 지방산 에스테르는, 예를 들면 자당 스테아린산 에스테르, 자당 팔미틴산 에스테르, 자당 미리스틴산 에스테르, 자당 올레인산 에스테르 또는 자당 라우린산 에스테르가 단독 또는 혼합되어 사용될 수 있으나 이에 제한되는 것은 아니다. 본 발명의 수성 나노에멀젼 조성물은 자당 지방산 에스테르를 0.1 내지 15 중량%, 더 바람직하게는 1 내지 10 중량%로 포함한다. 본 발명에서 자당 지방산 에스테르가 0.1 중량% 미만으로 포함되면 유화 안정성이 저하될 수 있으며, 15 중량%를 초과하여 포함되면 수성 조성물의 점성이 높아진다는 문제가 있을 수 있다.
The aqueous nanoemulsion composition of the present invention contains sucrose fatty acid ester as an auxiliary emulsifier in order to emulsify the mastic gum more stably. In the present invention, for example, sucrose fatty acid ester, sucrose stearic acid ester, sucrose palmitate ester, sucrose myristic acid ester, sucrose oleic acid ester or sucrose lauric acid ester may be used alone or in combination, but is not limited thereto. The aqueous nanoemulsion composition of the present invention comprises sucrose fatty acid ester in an amount of 0.1 to 15% by weight, more preferably 1 to 10% by weight. In the present invention, when the sucrose fatty acid ester is included in less than 0.1% by weight, the emulsion stability may be lowered, and when included in excess of 15% by weight, there may be a problem that the viscosity of the aqueous composition is increased.

본 발명의 수성 나노에멀젼 조성물은 매스틱검의 석출을 방지하고 상대적으로 적은 양의 유화제로 매스틱검을 용해하기 위하여 프로필렌글리콜을 포함한다. 본 발명의 수성 나노에멀젼 조성물은 프로필렌글리콜을 1 내지 40 중량%, 더 바람직하게는 5 내지 30 중량%로 포함한다 본 발명에서 프로필렌글리콜이 1 중량% 미만으로 포함되면 수성 나노에멀젼 조성물의 저장 안정성이 저하될 수 있고, 40 중량%를 초과하여 포함되면 에멀젼이 불안정하게 되어 분리될 수 있다.
The aqueous nanoemulsion composition of the present invention comprises propylene glycol to prevent precipitation of the mastic gum and to dissolve the mastic gum with a relatively small amount of emulsifier. The aqueous nanoemulsion composition of the present invention contains 1 to 40% by weight of propylene glycol, more preferably 5 to 30% by weight. In the present invention, when the propylene glycol is included in less than 1% by weight, the storage stability of the aqueous nanoemulsion composition is reduced. If included in excess of 40% by weight, the emulsion may become unstable and separate.

본 발명의 매스틱검 함유 수성 나노에멀젼 조성물은 상기 성분 이외에 잔량의 물, 예건대 5 내지 85 중량%의 물을 포함한다.The mastic gum-containing aqueous nanoemulsion composition of the present invention contains a residual amount of water, for example, 5 to 85% by weight of water in addition to the above components.

본 발명의 매스틱검 함유 수성 나노에멀젼 조성물은 바람직하게는 1 내지 100 cP(센티푸아즈)의 점도를 갖는다.The mastic gum-containing aqueous nanoemulsion composition of the present invention preferably has a viscosity of 1 to 100 cP (centipoise).

본 발명의 매스틱검 함유 수성 나노에멀젼 조성물은 생체이용률이 높아 적은 양으로 효능을 발휘할 수 있고, 뛰어난 저장 안정성을 가져서 상온(25℃)이나 고온(45℃)에서 장기간 보관하여도 석출이나 부유되지 않는다. 또한, 본 발명의 매스틱검 함유 수성 나노에멀젼 조성물은 넓은 범위의 pH(pH 2 내지 10)에서 매우 안정하기 때문에 다양한 제형으로 이용 가능하다. 본 발명의 매스틱검 함유 수성 나노에멀젼 조성물은 원하는 목적에 따라 음료, 식품, 화장품, 기능성식품 및 의약품 등의 다양한 분야에 적용될 수 있고, 이를 위하여 상기 언급한 성분 이외에도 점증제, 감미제, 부형제, 향료 등의 다양한 첨가제를 그 필요에 따라 추가로 포함할 수 있다.The mastic gum-containing aqueous nanoemulsion composition of the present invention has high bioavailability, can exhibit efficacy in a small amount, and has excellent storage stability, so that it does not precipitate or float even after long-term storage at room temperature (25 ° C) or high temperature (45 ° C). Do not. In addition, the mastic gum-containing aqueous nanoemulsion composition of the present invention is very stable at a wide range of pH (pH 2 to 10), and thus can be used in various formulations. Mastic gum-containing aqueous nanoemulsion composition of the present invention can be applied to various fields, such as beverages, food, cosmetics, functional foods and pharmaceuticals, depending on the desired purpose, for this purpose, in addition to the above-mentioned ingredients, thickeners, sweeteners, excipients, fragrances Various additives, such as these, can be further included as needed.

본 발명의 매스틱검 함유 수성 나노에멀젼 조성물은 뛰어난 저장 안정성, pH 안정성 및 투명성을 가질 뿐만 아니라, 효율적으로 매스틱검을 흡수시킬 수 있어 생체이용률이 높다.The mastic gum-containing aqueous nanoemulsion composition of the present invention not only has excellent storage stability, pH stability and transparency, but also can efficiently absorb mastic gum, and thus has high bioavailability.

도 1은 실시예 1의 나노에멀젼의 입자 직경의 크기를 Photal ELS-Z를 사용하여 측정한 결과이다.
도 2는 실시예 3의 나노에멀젼의 입자 직경의 크기를 Photal ELS-Z를 사용하여 측정한 결과이다.
도 3은 본 발명의 나노에멀젼을 동결 전자현미경을 사용하여 확대 촬영한 사진이다.
도 4는 매스틱검의 경피 흡수 결과를 촬영한 사진이다(A: Negative control(인산염 완충액); B: 글리세린을 포함하는 나노에멀젼; C: 프로필렌글리콜을 포함하는 나노에멀젼).
1 is a result of measuring the size of the particle diameter of the nanoemulsion of Example 1 using Photal ELS-Z.
2 is a result of measuring the size of the particle diameter of the nanoemulsion of Example 3 using Photal ELS-Z.
3 is an enlarged photograph of the nanoemulsion of the present invention using a frozen electron microscope.
Figure 4 is a photograph of the percutaneous absorption of the mastic gum (A: Negative control (phosphate buffer); B: nanoemulsion containing glycerin; C: nanoemulsion containing propylene glycol).

이하에서 본 발명을 실시예에 의하여 구체적으로 설명한다. 다만 실시예는 본 발명의 이해를 돕기 위하여 예시하는 것일 뿐 이에 의하여 본 발명의 범위가 제한되는 것은 아니다.
Hereinafter, the present invention will be described in detail by way of examples. However, the embodiments are only illustrated to help the understanding of the present invention, and the scope of the present invention is not limited thereto.

실시예Example 1 One

하기 표 1의 조성으로 다음의 방법에 의해 수성 나노에멀젼 조성물을 제조하였다. 매스틱검 파우더을 분쇄기로 파쇄한 후 올리브유에 용해하였다. 폴리글리세린 스테아린산과 자당 스테아린산 에스테르를 첨가한 후 물과 프로필렌글리콜을 넣고 충분히 교반한 다음, 고압미세유화기에서 1,000 bar로 연속 5회 통과시킨 후, 무균 여과하여 소분, 포장하였다. To the composition of Table 1 was prepared an aqueous nanoemulsion composition by the following method. The mastic gum powder was crushed with a grinder and dissolved in olive oil. After addition of polyglycerol stearic acid and sucrose stearic acid ester, water and propylene glycol were added and stirred well, and then passed five times at 1,000 bar continuously in a high-pressure microemulsifier, followed by sterile filtration and packaging.

Figure pat00001
Figure pat00001

실시예Example 2 2

하기 표 2의 성분을 사용한 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 제조하였다. It was prepared in the same manner as in Example 1, except that the components shown in Table 2 were used.

Figure pat00002
Figure pat00002

실시예Example 3 3

하기 표 3의 성분을 사용한 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 제조하였다.Except for using the components shown in Table 3, was prepared in the same manner as in Example 1.

Figure pat00003
Figure pat00003

실시예Example 4 4

하기 표 4의 성분을 사용한 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that the components shown in Table 4 were used.

Figure pat00004
Figure pat00004

실시예Example 5 5

하기 표 5의 성분을 사용한 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 제조하였다. It was prepared in the same manner as in Example 1, except that the components shown in Table 5 were used.

Figure pat00005
Figure pat00005

실험예Experimental Example 1 One

성상은 조성물을 조제한 후에 육안으로 층분리 및 석출 유무를 관찰하였으며 안정성은 상온(25℃) 및 45℃ 항온조에 보관하며 그 변화를 측정하였다.
After preparing the composition, the appearance was visually observed for layer separation and precipitation. Stability was stored at room temperature (25 ° C.) and 45 ° C. constant temperature bath and the change was measured.

1) 나노에멀젼 조성물의 층분리, 석출, 안정성1) Layer Separation, Precipitation, and Stability of Nanoemulsion Composition

Figure pat00006
Figure pat00006

2) 매스틱검의 변색 변화를 상온(25℃)과 고온(45℃)에서 실시예 1 내지 5를 2년간 관찰결과 색의 변화가 없었다.
2) The color change of the mastic gum was observed at room temperature (25 ° C.) and high temperature (45 ° C.) in Examples 1 to 2 for two years, and there was no change in color.

3) pH 안정성3) pH stability

pH 2, 5, 7 및 10에서의 pH 안정성을 상온(25℃)에서 육안으로 관찰하여 그 결과를 다음의 표 7에 나타내었다.pH stability at pH 2, 5, 7 and 10 was visually observed at room temperature (25 ° C.) and the results are shown in Table 7 below.

Figure pat00007
Figure pat00007

상기 결과로부터 본 발명에 따른 수성 조성물이 뛰어난 저장 안정성, 변색이 없는 투명성 및 넓은 범위의 pH에서 안정성을 가지고 있음을 알 수 있었다.
From the above results, it was found that the aqueous composition according to the present invention had excellent storage stability, transparency without discoloration, and stability at a wide range of pH.

실험예Experimental Example 2:  2: 나노에멀젼의Of nanoemulsion 입자 분포 측정 Particle distribution measurement

실시예 1 및 3에서 제조된 나노에멀젼의 입자 분포를 Photal ELS-Z를 이용하여 측정한 다음 각각 도 1 및 도 2에 나타내었다. 측정 결과 입자의 직경 크기가 실시예 1은 350㎚이고, 실시예 3은 90㎚임을 알 수 있었다.
The particle distribution of the nanoemulsions prepared in Examples 1 and 3 was measured using Photal ELS-Z and then shown in FIGS. 1 and 2, respectively. As a result, it was found that the diameter of the particles was 350 nm in Example 1 and 90 nm in Example 3.

실험예Experimental Example 3:  3: 나노에멀젼Nano Emulsion 입자 촬영 Particle shooting

실시예 3에서 제조된 나노에멀젼의 입자를 촬영하였다. 나노에멀젼의 입자 크기가 너무 미세하여 일반적인 광학 현미경으로는 측정이 불가능하기에 동결 전자현미경(JEM 1010, JEOL사, 일본)을 이용하여 촬영하였다(도 3). 도 3으로부터 나노에멀젼이 비교적 균일한 크기로 잘 형성되었음을 알 수 있었다.
Particles of the nanoemulsion prepared in Example 3 were taken. Since the particle size of the nanoemulsion was too fine to be measured by a general optical microscope, it was photographed using a frozen electron microscope (JEM 1010, JEOL, Japan) (FIG. 3). It can be seen from FIG. 3 that the nanoemulsion was well formed with a relatively uniform size.

실험예Experimental Example 4:  4: 매스틱검의Mastic 경피Transdermal 흡수촉진 효과 실험 Absorption Promotion Effect Experiment

8주 정도의 암컷 무모 기니아피그(strain IAF/HA-hrBR)를 이용하였다. 기니아피그의 복부 피부를 절취한 후 Franz-type diffusion cell(Lab fine instruments, 한국)에 장착하여 실험하였다. Franz-type diffusion cell의 receptor 용기(5 ㎖)에 50mM 인산염 완충액(pH 7.4, 0.1M NaCl)을 넣어준 후, diffusion cell을 32℃에서 600 rpm으로 혼합, 분산시켜 주었으며, 매스틱검은 정량적인 측정이 어렵기에 수용성이고 세포 및 경피 흡수시 염색에 사용되는 시약인 FITC(fluorescein isothiocyanate)를 사용하여 실험하였다. FITC와 나노에멀젼 50㎕를 donor용기에 넣어 주었다. 미리 예정한 시간에 따라 흡수 확산시켜 주었으며, 흡수 확산이 일어나는 피부는 0.64 cm2가 되게 하였다. 유효성분의 흡수확산이 끝난 후에 건조된 kimwipes 또는 10 ㎖의 에탄올로 흡수되지 못하고 피부에 남아있는 유화물을 씻어준 다음 팁-타입 균등기를 사용하여 유효성분이 흡수 확산되어 receptor chamber에 투과되어 나온 형광물질 양상을 관찰하였다 (도 4).Female hairless guinea pigs (strain IAF / HA-hrBR) of about 8 weeks were used. The abdominal skin of the guinea pig was excised and mounted in a Franz-type diffusion cell (Lab fine instruments, Korea). 50mM phosphate buffer (pH 7.4, 0.1M NaCl) was added to the receptor vessel (5 ml) of the Franz-type diffusion cell, and the diffusion cell was mixed and dispersed at 600 rpm at 32 ° C. Due to this difficulty, experiments were performed using fluorescein isothiocyanate (FITC), a reagent that is water soluble and used for staining upon cellular and transdermal absorption. 50 μl of FITC and nanoemulsion were placed in a donor container. Absorption and diffusion were carried out according to a predetermined time, and the skin where absorption and diffusion occurred was 0.64 cm 2 . After absorption and diffusion of the active ingredient, the dried kimwipes or the 10 ml of ethanol are not absorbed and the emulsion remaining on the skin is washed. Then, the tip is spread using the tip-type equalizer to diffuse and diffuse the active ingredient into the receptor chamber. Was observed (FIG. 4).

도 4의 형광물질 흡수 양상에서 볼 수 있듯이, 본 발명에 따른 수성 나노에멀젼 조성물은 효율적으로 매스틱검을 경피 흡수시키는 것을 알 수 있었으며, 특히 프로필렌글리콜을 포함하는 나노에멀젼이 글리세린을 포함하는 나노에멀젼에 비하여도 경피 흡수율이 훨씬 뛰어남을 알 수 있었다.As can be seen in the fluorescent material absorption aspect of Figure 4, the aqueous nanoemulsion composition according to the present invention was found to efficiently absorb transdermal mastic gum, in particular, the nanoemulsion containing propylene glycol is in the nanoemulsion containing glycerin Compared to the percutaneous absorption rate was much better.

Claims (6)

매스틱검 5 내지 60 중량%, 오일 5 내지 50 중량%, 유화제로 폴리글리세린 지방산 에스테르 3 내지 30 중량%, 보조 유화제로 자당 지방산 에스테르 0.1 내지 15 중량%, 프로필렌글리콜 1 내지 40 중량% 및 잔량의 물을 포함하는 매스틱검 함유 수성 나노에멀젼 조성물.5 to 60% by weight of mastic gum, 5 to 50% by weight of oil, 3 to 30% by weight of polyglycerin fatty acid ester as emulsifier, 0.1 to 15% by weight of sucrose fatty acid ester as auxiliary emulsifier, 1 to 40% by weight of propylene glycol and the balance A mastic gum-containing aqueous nanoemulsion composition comprising water. 제1항에 있어서, 점도가 1 내지 100 cP인 것을 특징으로 하는 매스틱검 함유 수성 나노에멀젼 조성물.The mastic gum-containing aqueous nanoemulsion composition according to claim 1, wherein the viscosity is 1 to 100 cP. 제1항에 있어서, 오일이 올리브유, 해바라기유, MCT(medium chain triglyceride), 호호바유 및 마카다미아넛오일로 이루어지는 그룹에서 선택되는 하나 이상인 것을 특징으로 하는 매스틱검 함유 수성 나노에멀젼 조성물.The mastic gum-containing aqueous nanoemulsion composition according to claim 1, wherein the oil is at least one selected from the group consisting of olive oil, sunflower oil, medium chain triglyceride (MCT), jojoba oil and macadamia nut oil. 제1항에 있어서, 폴리글리세린 지방산 에스테르가 폴리글리세린 스테아린산, 폴리글리세린 미리스틴산, 폴리글리세린 올레인산 및 폴리글리세린 라우린산으로 이루어지는 그룹에서 선택되는 하나 이상인 것을 특징으로 하는 매스틱검 함유 수성 나노에멀젼 조성물.The mastic gum-containing aqueous nanoemulsion composition according to claim 1, wherein the polyglycerol fatty acid ester is at least one selected from the group consisting of polyglycerol stearic acid, polyglycerin myristic acid, polyglycerol oleic acid, and polyglycerol lauric acid. . 제1항에 있어서, 자당 지방산 에스테르가 자당 스테아린산 에스테르, 자당 팔미틴산 에스테르, 자당 미리스틴산 에스테르, 자당 올레인산 에스테르 및 자당 라우린산 에스테르로 이루어지는 그룹에서 선택되는 하나 이상인 것을 특징으로 하는 매스틱검 함유 수성 나노에멀젼 조성물.The aqueous mastic gum-containing aqueous solution according to claim 1, wherein the sucrose fatty acid ester is at least one selected from the group consisting of sucrose stearic acid ester, sucrose palmitate ester, sucrose myristic acid ester, sucrose oleic acid ester and sucrose lauric acid ester. Nanoemulsion Composition. 제1항 내지 제5항 중 어느 한 항의 매스틱검 함유 수성 나노에멀젼 조성물을 포함하는 화장품 또는 식품.A cosmetic or food comprising the mastic gum-containing aqueous nanoemulsion composition of any one of claims 1 to 5.
KR1020100081556A 2010-08-23 2010-08-23 Aqueous nanoemulsion composition containing mastic gum KR20120018609A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100081556A KR20120018609A (en) 2010-08-23 2010-08-23 Aqueous nanoemulsion composition containing mastic gum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100081556A KR20120018609A (en) 2010-08-23 2010-08-23 Aqueous nanoemulsion composition containing mastic gum

Publications (1)

Publication Number Publication Date
KR20120018609A true KR20120018609A (en) 2012-03-05

Family

ID=46127823

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100081556A KR20120018609A (en) 2010-08-23 2010-08-23 Aqueous nanoemulsion composition containing mastic gum

Country Status (1)

Country Link
KR (1) KR20120018609A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180055331A (en) * 2016-11-17 2018-05-25 주식회사 프롬바이오 Method for production of mastic gum solution with high dispersion activity and solubilization activity by nanoparticle system
KR101971404B1 (en) * 2018-08-09 2019-04-22 장세순 Method for liquefying mastic gum and a mastic gum solution prepared thereby
KR20200135111A (en) * 2019-05-23 2020-12-02 가천대학교 산학협력단 Composition for preventing or treating periodontal disease containing mastic gum-encapsulated lipid nanoparticle as an active ingredient with improved solubility and anti-inflammatory effect
KR102246935B1 (en) * 2020-11-25 2021-04-30 주식회사 프롬바이오 Method for the production of ethanol hand sanitizer with antibacterial persistence by using soluble mastic gum
WO2022203145A1 (en) * 2021-03-22 2022-09-29 주식회사 앱스바이오 Lipid nanoparticle composition prepared using mastic gum or gamma oryzanol

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180055331A (en) * 2016-11-17 2018-05-25 주식회사 프롬바이오 Method for production of mastic gum solution with high dispersion activity and solubilization activity by nanoparticle system
KR101971404B1 (en) * 2018-08-09 2019-04-22 장세순 Method for liquefying mastic gum and a mastic gum solution prepared thereby
KR20200135111A (en) * 2019-05-23 2020-12-02 가천대학교 산학협력단 Composition for preventing or treating periodontal disease containing mastic gum-encapsulated lipid nanoparticle as an active ingredient with improved solubility and anti-inflammatory effect
KR102246935B1 (en) * 2020-11-25 2021-04-30 주식회사 프롬바이오 Method for the production of ethanol hand sanitizer with antibacterial persistence by using soluble mastic gum
WO2022203145A1 (en) * 2021-03-22 2022-09-29 주식회사 앱스바이오 Lipid nanoparticle composition prepared using mastic gum or gamma oryzanol

Similar Documents

Publication Publication Date Title
EP1993515B1 (en) Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof
JP2023109849A (en) Dilutable formulations of cannabinoids and processes for their preparation
KR101653886B1 (en) Natural Preservative Composition
Hasnain et al. Formulation and ex vivo skin permeation of lidocaine HCl topical gels using dillenia (Dillenia indica L.) fruit gum
KR20120018609A (en) Aqueous nanoemulsion composition containing mastic gum
US9789146B1 (en) Synthesis of adansonia digitata nanoparticles
TWI830456B (en) A method for improving the stability of p-hydroxyacetophenone in cosmetic compositions
CN109589278A (en) The preparation process of high stable prinsepia utilis royle oil liposome and its application in cosmetics
Saleh et al. Optimization and characterization of lippia citriodora essential oil loaded niosomes: a novel plant-based food nano preservative
CN105581924B (en) A kind of compound cassia bark oil nanometer emulsion and preparation method thereof
JP2015227354A (en) Oil-in-water emulsion of mometasone and propylene glycol
CN105380873B (en) A kind of replenishing water and preserving moisture essence containing oil of Nitraria seeds
TR202008828A2 (en) METHOD OF OBTAINING HIPPOPHAE RHAMNOIDES EXTRACT ENCAPSULATED WITH LIPOSOMAL TECHNOLOGY FOR USE IN COSMETIC FORMULAS
ES2645648T3 (en) Cosmetic and / or dermatological product based on a cork extract, at least a part of the tree that provides the cork, and at least one natural fatty body, its preparation procedure and the composition that contains it
KR101882657B1 (en) Cosmetic Composition Comprising Nipa Palm Extract
KR101410042B1 (en) Composition of moisturizing cosmetics containing propolis nano-vesicle
CN113440453A (en) Composite whitening active matter nanoparticles and preparation method and application thereof
JP6348024B2 (en) Silymarin-containing composition with good water dispersibility
KR102042453B1 (en) Soluble type idebenone stabilizing composition, manufacturing method thereof and cosmetic composition using the same
TR202011889A1 (en) Gel formulation created with okra fruit extract and the use of this gel formulation as a wound healer
KR101228967B1 (en) Cosmetic composition containing pear and method of the same
Fateh et al. Design, Development and in Vitro Characterization of Emulgels Loaded with Fluconazole Solid Dispersion and Various Oils for Synergestic Anti-Fungal Effect.
CN115737727B (en) Pharmaceutical composition for treating aspirin-induced gastric mucosal injury
DK2429490T3 (en) OIL-IN-WATER EMULSION OF MOMETASON
Azlan et al. Mini Review The Role of Natural Plants with Incorporation of Tocopherols, Ubiquinone and Tocotrienols in Nanoemulsion Formulation: A Mini

Legal Events

Date Code Title Description
A201 Request for examination
E601 Decision to refuse application